Navigation
banner
Together we Drive the Future

Antibody & Protein Therapeutics Summit

2017-04-272017-06-112017-05-11
EARLY BIRD DISCOUNT! Register by May 11, 2017 to receive 20% off your registration!
Or Register 3 for the price of 2 with the coupon code rcdvb!


registration button

Antibody & Protein Therapeutics Summit


Antibodies in Oncology & Beyond

Antibody Drug Conjugates

Novel Protein Therapeutics
 
 

Subscribe for updates



Dear Colleague,

Although antibody-drug conjugates and protein therapeutics now play a significant role in the treatment and diagnosis of diseases, this field is continuously evolving with novel and innovative next-generation therapeutics on the horizon.  Therefore, we invite you to attend the Antibody & Protein Therapeutics Summit to be held at the Royal Sonesta Harbor Court on July 11-12, 2017 in Baltimore, MD. The summit is the ideal venue to network with academic and pharmaceutical industry scientists, providing access to over 60 presentations from leading experts and will feature the latest advances in antibody and protein therapeutic research, including clinical findings.

This summit is comprised of three complimentary tracks that seek to drive the discovery, development and application of antibody & protein therapies.  Track 1 – Antibodies in Oncology & Beyond will provide sessions exploring antibody discovery strategies and the development of antibodies and proteins for cancer immunotherapy and infectious diseases.  Track 2 – Antibody Drug Conjugates will provide numerous sessions spanning basic discovery and development to important clinical findings.  Track 3 – Novel Protein Therapeutics will provide innovative ideas in protein design and engineering.  The sessions will also highlight advances in emerging antigen discovery in disease and applications with radioactive payloads.

Join us to network with colleagues to discuss the methods and tools used in developing effective next-generation antibody-drug conjugates and protein therapeutics to “drive the future of science.”

We hope to see you there!   

Best regards,

The 2017 Advisory Committee

2017 Program Director
Victor-Jeffrey Leyton, Université de Sherbrooke
2017 Advisory Board Members
Neeraj Agrawal, Amgen
Ahuva Nissim, Queen Mary University
Amandeep Gakhal, Sutro Biopharma
Ann White, University of Southampton
Bill Harriman , Crystal Bioscience
Birgit Schoeberl, Merrimack Pharmaceuticals
Elad Firnberg, Revolve Biotechnologies
Ernesto Freire, Johns Hopkins University
Nicolas Fischer, Novimmune SA
Gregory Adams, Eleven Biotherapeutics
Janos Luka, Walter Reed Army Institute of Research
Matthew Robinson, Immunome, Inc
Michael R. Dyson, IONTAS Ltd
Andreas Pahl, Heidelberg Pharma
Pedro Berraondo López, CIMA, University of Navarra
Darren Schofield, MedImmune
Seema Kumar, EMD Serono
Jamshid Tanha, University of Ottawa
Thomas Pillow, Genentech
Medha J. Tomlinson, Abbvie
Yan Chen, Genentech